Technical420 Site Search

When it comes to the Latin America cannabis market, we consider Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) to be a clear leader. We believe the Latin American cannabis operator is in the early innings of a major growth cycle and is well positioned to capitalize on…

Last week, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) reported strong first quarter financial results and announced several new company records. From the number of prescriptions filled to the amount of revenue generated, Khiron’s first quarter financial results showed impressive growth on several key metrics and our…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , is pleased to announce the receipt of the Company's largest ever shipment of EU-GMP certified medical cannabis product for…

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today its financial results for the quarter ended March 31, 2021. These filings are available for review on the Company's SEDAR profile at www.sedar.com. All financial information in this press release is…

A few weeks ago, Khiron published fourth quarter financial results and we are favorable on how the business is positioned to record strong growth on a going forward basis.  Reports Ramping Revenues While Cutting Expenses During the quarter, Khiron reported that revenues grew more than 30% on a quarter-over-quarter basis…

Earlier this month, Mexico’s push to legalize recreational cannabis was halted after Senate Majority Leader Ricardo Monreal said that is attempting to extend the Supreme Court’s deadline to change the current law. This development was not well received by the market as Mexico was on the verge of becoming the…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today its financial results for the year ended and quarter ended December 31, 2020. These filings are available for review on the Company's SEDAR profile at www.sedar.com. All financial…

One of the most exciting trends in the global cannabis industry is related to the US market and how it has been reporting impressive growth on a year-over-year basis. During the last few years, we noticed a trend where broker-dealers or market research firms that are focused on the cannabis…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully exported its registered Colombian cannabis strains, in the form of live clones, to Europe.…

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe , is pleased to announce that the Company has successfully delivered EU-GMP medical cannabis product to Germany . In collaboration with Nimbus Health, a leading…